Epidermal Fatty Acid Binding Protein Promotes Skin Inflammation Induced by High-Fat Diet  by Zhang, Yuwen et al.
ArticleEpidermal Fatty Acid Binding Protein Promotes Skin
Inflammation Induced by High-Fat DietHighlightsd Consumption of a high-fat diet (HFD) induces inflammatory
skin lesions
d HFD promotes CD11c+ macrophage infiltration and NLRP3
inflammasome activation
d E-FABP couples lipid transportation and IL-1b and IL-18
production
d Deficiency of E-FABP protects mice against HFD-induced
skin inflammationZhang et al., 2015, Immunity 42, 953–964
May 19, 2015 ª2015 Elsevier Inc.
http://dx.doi.org/10.1016/j.immuni.2015.04.016Authors
Yuwen Zhang, Qiang Li, ...,
Margot P. Cleary, Bing Li
Correspondence
bli@hi.umn.edu
In Brief
How obesity instigates chronic skin
inflammation remains largely unknown. Li
and colleagues show that a high-fat diet
promotes the accumulation of a specific
type of CD11+ macrophages in skin,
which are activated to induce IL-1b- and
IL-18-mediated skin inflammation in an E-
FABP-dependent manner.
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Defining specific cellular and molecular mechanisms
in most obesity-related diseases remains an impor-
tant challenge. Here we report a serendipitous
finding that consumption of a high-fat diet (HFD)
greatly increased the occurrence of skin lesions in
C57BL/6 mice. We demonstrated that HFD induced
the accumulation of a specific type of CD11c+ mac-
rophages in skin preceding detectable lesions.
These cells primed skin to induce IL-1b and IL-18
signaling, which further promoted the cytokines
IFN-g- and IL-17-mediated skin inflammation.
Mechanistically, epidermal fatty acid binding protein
(E-FABP) was significantly upregulated in skin of
obese mice, which coupled lipid droplet formation
and NLRP3 inflammasome activation. Deficiency
of E-FABP in obese mice decreased recruitment
of CD11c+ macrophages in skin tissues, reduced
production of IL-1b and IL-18, and consequently
dampened activation of effector T cells. Further-
more, E-FABP-deficient mice are completely resis-
tant to HFD-induced skin lesions. Collectively,
E-FABP represents a molecular sensor triggering
HFD-induced skin inflammation.
INTRODUCTION
Increased food intake and decreased energy expenditure
have mainly contributed to the epidemic of obesity worldwide
over the past several decades (Hill et al., 2012). Due to
the adverse effects of obesity on public health, intensive
research has been focused on how obesity is mechanistically
linked to metabolic inflammation and various diseases,
including type 2 diabetes, cardiovascular diseases, and
certain types of cancer (Gregor and Hotamisligil, 2011).
Mounting evidence has indicated that inflammasome-acti-
vated IL-1b and IL-18 responses are essential in promoting
obesity-induced inflammation and insulin resistance (Stienstra
et al., 2010; Vandanmagsar et al., 2011). However, it remains
to be determined whether the inflammasome-activatedsignaling represents a general mechanism for other obesity-
related diseases.
Fatty acid binding proteins (FABPs) are a group of intracel-
lular chaperones coordinating lipid trafficking and biological
functions (Furuhashi and Hotamisligil, 2008; Chmurzynska,
2006). FABPs have traditionally been named according to
the tissue in which they were originally identified, such as
adipose FABP (A-FABP) or epidermal FABP (E-FABP; en-
coded by Fabp5), but their actual expression profiles and
functions are more complicated than previously thought
(Smathers and Petersen, 2011). For example, we have
demonstrated that E-FABP, beyond being present in kerati-
nocytes in skin epidermis, is widely expressed in immune
cells, including T cells and macrophages, where it regulates
their immunological functions (Li et al., 2009; Zhang et al.,
2014). It has been shown that dietary fatty acids (FAs) can
induce the production of IL-1b and IL-18 by activating the
NLRP3 (nucleotide-binding domain, leucine-rich repeats con-
taining family, pyrin domain-containing-3) inflammasome
pathway in macrophages from HFD-induced obese mice
(Wen et al., 2011). Because of the central roles of FABPs
in facilitating fatty acid transport and metabolism, it is very
likely that FABPs play a critical role in regulating obesity-
induced inflammasome signaling.
In our experiments with HFD-induced models of obesity with
C57BL/6 mice, the veterinary staff frequently euthanized obese
mice because of skin lesions. Although aged mice with C57BL/
6 genetic background are known to be susceptible to inflam-
matory skin lesions, such as ulcerative dermatitis (Kastenmayer
et al., 2006; Williams et al., 2012), a high incidence of skin
lesions observed only in the obese mice in our experimental
settings clearly suggests that, besides genetic factors, the
HFD significantly contributes to skin inflammation. Given the
unknown etiology of ulcerative dermatitis syndrome in mice
(Duarte-Vogel and Lawson, 2011; Sundberg et al., 2011) and
the poor understanding of obesity-associated inflammatory
skin diseases in humans (Yosipovitch et al., 2007; Shipman
and Millington, 2011; Scheinfeld, 2004; Mathur and Goebel,
2011; Mirmirani and Carpenter, 2014), we set out to dissect
the cellular and molecular mechanisms of how the HFD,
as a major environmental factor, promotes inflammatory
skin lesions. Here, we provide evidence to establish E-FABP
as a new molecular sensor in triggering HFD-induced skin
inflammation.Immunity 42, 953–964, May 19, 2015 ª2015 Elsevier Inc. 953
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Figure 1. HFD Induces Inflammatory Skin Lesions in Mice
(A) C57BL/6 mice were grouped and fed the HFD (60% fat) or the LDF (10% fat) (n = 16/group), respectively. Average body weight of each group was shown from
3 months to 6 months on special diets (**p < 0.01).
(B) Representative pictures of a LFD-fed mouse and a mouse with a HFD-induced lesion.
(C) Skin lesion incidence in mice fed with the LFD or the HFD for 9 months (n = 16/group) (**p < 0.01).
(D) Skin lesion incidence in mice with 10% fat diet (n = 60), 33% fat diet (n = 63), and 60% fat diet (n = 21) for 9 months (*p < 0.05; **p < 0.01).
(E) Hematoxylin and eosin (H&E) staining of skin tissues from LFD-fed mice, normal HFD-fed mice, and lesional HFD-fed mice. Scale bars represent 100 mM.
Data are shown as mean ± SEM and are representative of two to three experiments.RESULTS
High-Fat Diet Induces Inflammatory Skin Lesions in
Obese Mice
To study diet-induced obesity models, C57BL/6 mice were
randomly grouped and fed on a control low-fat diet (LFD, 10%
fat) or a high-fat diet (HFD, 60% fat) after weaning. Body weight
was significantly increased in the group on the HFD as compared
to the group on the LFD after 3 months (Figure 1A). When we
continued to maintain these mice on the same diet for 6 months,
mice on the HFD began spontaneously to develop detectable
skin lesions (Figure 1B). We found that approximately 40% of
the obese mice developed skin lesions after 9 months on the
HFD, whereas none of mice on the LFD exhibited similar skin
problems (Figure 1C). The base ingredients of the two diets
were identical except for the fat content (Warden and Fisler,
2008), so we reasoned that skin lesions in the obese mice
were attributed to the high fat content. We further analyzed the
incidence of skin lesional mice fed diets of various amounts of
fat and demonstrated that the skin lesions were positively asso-
ciated with the fat content in the food, namely, the higher amount
of fat in the diet, the more skin lesions in the mice (Figure 1D).
Histological staining of skin tissues with hematoxylin and eosin
showed that inflammatory cells started emerging in the normal
skin of obese mice and accumulated in the lesional skin (Fig-
ure 1E). Moreover, skin lesions occurred in different locations
of the obese mice, including the areas of neck, flank, and leg.
To further confirm this observation, we deliberately induced
skin lesions of LFD- or HFD-fed mice in a felt wheel skin abrasion
model. Skin lesions in HFD-fed mice were much severe than954 Immunity 42, 953–964, May 19, 2015 ª2015 Elsevier Inc.those in LFD-fed mice. Altogether, our data clearly indicate
that the HFD is a major environmental factor to promote inflam-
matory skin lesions in both spontaneous and artificial mouse
models.
HFD Promotes the Infiltration of CD11c+ Macrophages
in Skin
To investigate how consumption of the HFD induces inflamma-
tory skin lesions in obese mice, we hypothesized that HFD
might alter the phenotype of immune cell populations in skin.
First, we analyzed the immune cell profile in skin samples
obtained from LFD-fed lean mice and HFD-fed obese mice
without skin lesions. There were no or very few B cells, CD8+
T cells, and neutrophils in the skin of these mice, and CD4+
T cells, NK cells, and gd+CD3+ T were present in skin but
showed no obvious differences between lean mice and obese
mice. However, we noticed that CD11c+F4/80+ macrophages
were significantly elevated in skin of obese mice (0.57% ±
0.04%) as compared to lean mice (0.27% ± 0.024%) (Fig-
ure S1A). Increase of CD11c+F4/80+ macrophage numbers
in obese mice was further confirmed when we analyzed the
peripheral blood from these mice (Figure S1B). These data indi-
cate that HFD systemically increases CD11c+F4/80+ macro-
phages and promotes accumulation of this population in skin
tissues preceding detectable lesions. CD11c+F4/80+ macro-
phages have been shown to infiltrate into adipose tissues to
promote inflammation and insulin resistance (Patsouris et al.,
2008; Lumeng et al., 2007), so it is very likely that this popu-
lation is responsible for the initiation of skin pathogenesis in
HFD-induced obese mice.
Normal Skin                                                           Lesion Skin
F4/80
C
D
11
c
A
B
Normal Skin                                 Lesion Skin
1
2
1
2
2
1 1
2
0.23% 1.28%
No
rm
al
Sk
in
Le
sio
n S
kin
0.0
0.5
1.0
1.5
p=0.024
C
D
11
c+
F4
/8
0+
ce
lls
(%
)
CD11b                             F4/80                                CD11c                             MHCII  
  CD103                             CD206                             CD207                             CD301b
Isotype control obese micelean mice
CD8a                                Ly6C                                CD45                               CD64
C
Figure 2. HFD Promotes the Accumulation
of CD11c+ Macrophages in Obese Mice
(A) Analysis of the accumulation of CD11c+ mac-
rophages in skin tissues from LFD-fed normal mice
and HFD-fed lesional mice by flow cytometry.
Average percentage of CD11c+ macrophages in
skin is shown in the right panel.
(B) Frozen sections of skin tissues from LFD-fed
normal mice and HFD-fed lesional mice were
stained with F4/80 mAb (red) and DAPI (blue) for
confocal microscopy analysis. Magnified fields of
selected areas are shown in the right panel. Scale
bars represent 10 mM.
(C) Phenotypic characterization of HFD-elevated
skin macrophages by flow cytometric analysis.
Data are shown as mean ± SEM and representa-
tive of at least three experiments. See also Fig-
ure S1.We next analyzed tissues from HFD-fed skin lesion mice
by focusing on the CD11c+F4/80+ population. Indeed, we
found by flow cytometric analysis that these cells were more
than 5-fold numerous in lesional skin than in normal skin of
LFD-fed mice (Figure 2A). Confocal microscopic analysis
clearly showed that these cells accumulated throughout
the lesional skin including both epidermis and dermis (Figure 2B).
To further characterize these HFD-elevated skin macrophages,Immunity 42, 953–we demonstrated that they exhibited
a CD11b+MHCII+F4/80+CD11c+CD103
CD207+(langerin)CD301bLy6CCD45+
CD206CD64CD8a phenotype (Fig-
ure 2C). In addition, enhanced expres-
sion intensity of CD11b on macrophages
from the obese mice suggests that they
originate from hematopoietic precursors
(Schulz et al., 2012). Because these
CD11c+F4/80+ cells expressed high
amounts of MHC class II, exhibiting
essential capacity for antigen presenta-
tion (Murray and Wynn, 2011; Hume,
2008), we further examined their pres-
ence in peripheral lymph organs. Drain-
ing lymph nodes (LNs) and the spleen
from the skin lesional mice exhibited
significantly increased percentage of
CD11c+F4/80+ macrophages compared
to those from normal mice (Figures S1C
and S1D). Phenotypically, they exhibited
CD11b+MHCII+F4/80+CD11c+CD103
CD207dimCD301bLy6CCD45+CD206
CD64CD8a+ in LNs (Figure S1E),
while displaying a CD11b+MHCII+F4/80+
CD11c+CD103CD207dimCD301bLy6C
CD45+CD206CD64+CD8a phenotype
in the spleen (Figure S1F). Of note, there
were no obvious changes regarding the
percentage of CD11c single-positive
cells (Figures S1B and S1D), suggesting
that CD11c+F4/80+ macrophages arespecifically upregulated to mediate skin inflammation upon
consumption of the HFD.
Upregulation of IL-1b and IL-18 Production in
HFD-Induced Lesion Skin
To further determine the molecular mechanism underlying the
HFD-induced skin inflammation, we first analyzed the overall
profiles of inflammatory cytokines and related factors in skin964, May 19, 2015 ª2015 Elsevier Inc. 955
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Figure 3. Upregulation of IL-1b and IL-18
Production in HFD-Induced Skin Lesions
(A and B) Keratinocytes, CD11c+ macrophages,
and gd T cells were separated by a flow sorter from
either normal skin tissues or HFD-induced lesional
skin tissues. Relative levels of IL-1bmRNA (A) and
IL-18 mRNA (B) were determined by quantitative
real-time PCR (*p < 0.05; **p < 0.01).
(C and D) Keratinocytes, CD11c+ macrophages,
and gd T cells were separated by a flow sorter from
felt-wheel-induced lesional skin tissues from lean
or obese mice. Relative levels of IL-1b mRNA (A)
and IL-18 mRNA (B) were determined by quanti-
tative real-time PCR (*p < 0.05).
(E and F) Measurement of IL-1b (E) and IL-18 (F) by
ELISA in supernatants of primary keratinocytes or
CD11c+ macrophages stimulated with designated
conditions for 24 hr (LPS, 100 ng/ml; FAs, 200 mM
palmitate) (*p < 0.05; **p < 0.01).
Data are shown as mean ± SEM and are repre-
sentative of at least three experiments. See also
Table S1 and Figure S2.tissues. In HFD-induced spontaneous lesional skin tissues,
we found that inflammasome-related cytokines IL-1b and
IL-18 were remarkably upregulated as compared to those in
normal skin tissues (Table S1, first column), suggesting that
inflammasome signaling is involved in the HFD-induced inflam-
mation. Moreover, when we compared cytokine profiles in
the lesional skin between lean mice and obese mice in the
felt-wheel-induced model, we further confirmed that IL-1b
and IL-18 were significantly elevated in obese mice (Table
S1, second column). Thus, evidence from both spontaneous
and artificial models consistently indicates that IL-1b and
IL-18, but not other obesity-related cytokines, such as IL-6 or
TNF-a, were the major responses mediating the HFD-promoted
skin inflammation.
To dissect the cellular sources of these cytokines, we sepa-
rated major populations in the skin, including keratinocytes,
CD11c+F4/80+ macrophages, and gd T cells, with a flow sorter
(Figure S2). In the HFD-induced spontaneous model, IL-1b
mRNA was expressed predominantly in CD11c+F4/80+ macro-956 Immunity 42, 953–964, May 19, 2015 ª2015 Elsevier Inc.phages, lowly in keratinocytes, and non-
detectably in gd T cells (Figure 3A). In
contrast, IL-18 mRNA was present in
both keratinocytes and macrophages
but was undetectable in gd T cells (Fig-
ure 3B). Consistently, similar results
were observed in the felt-wheel-induced
skin lesional model (Figures 3C and 3D),
confirming that CD11c+F4/80+ macro-
phages are the major source of IL-1b
and IL-18 in skin tissues. More impor-
tantly, addition of palmitic acid, the
most abundant saturated fatty acids
(FAs) in the HFD, significantly stimulated
LPS-primed CD11c+ macrophages to
secrete IL-1b and IL-18 proteins,
although neither LPS nor FAs alone was
able to stimulate IL-1b and IL-18 secre-tion (Figures 3E and 3F), implying that IL-1b- and IL-18-mediated
skin inflammation requires at least two signals, one from non-
sterile environmental factors and the other from consumption
of the HFD. Based on these findings and evidence from other
documented research (Stienstra et al., 2010; Vandanmagsar
et al., 2011; Hoffman et al., 2004), our results suggest that HFD
promotes CD11c+F4/80+ macrophage accumulation in skin
and facilitates their production of IL-1b and IL-18 in a non-sterile
environment to initiate skin inflammation. In addition, keratino-
cytes might also be involved in sustaining skin lesions by secre-
tion of IL-18.
HFD-Induced Lesion Mice Are Associated with
Enhanced T Cell Activation
In addition to the upregulation of IL-1b and IL-18, IFN-g and
IL-17 were also significantly elevated in lesional skin tissues
(Figure 4A). Considering that IL-1b and IL-18 are well
known for promoting Th1- and Th17-cell-mediated responses
(Chung et al., 2009; Netea et al., 2010; Joosten, 2010),
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Figure 4. HFD-Induced Lesions Are Associ-
ated with Enhanced T Cell Activation
(A) Analysis of the relative mRNA levels of IFN-g
and IL-17 in skin tissues from LFD-fed normal
mice and HFD-fed lesional mice by real-time PCR
(*p < 0.05).
(B) Flow cytometric analysis for CD4+ T cells and
CD8+ T cells in skin epidermis of LFD-fed normal
mice and HFD-fed lesional mice. Average per-
centage of T cells in skin epidermis is shown in
the right panel (**p < 0.01).
(C andD) Frozen sections of skin tissues from LFD-
fed normal mice (C) and HFD-fed lesional mice (D)
were stained with CD4 mAb (green), CD8 mAb
(red), and DAPI (blue) for confocal microscopic
analysis. Magnified fields of selected areas are
shown in the right panel of each figure. Scale bars
represent 10 mM.
(E and F) Flow cytometric analysis of the activation
status of CD4+ T cells (E) and CD8+ T cells (F) in
draining lymph nodes (LNs) from LFD-fed normal
mice and HFD-fed lesional mice. Data represent
one of three independent experiments with
similar results.
(G–I) Analysis of IFN-g production in CD4+ T cells
(G) and CD8+ T cells (H) of draining LNs from
LFD-fed normal mice and HFD-fed lesional mice
by intracellular staining. Average percentage of
IFN-g+ cells in total CD4+ or CD8+ T cells is shown
in (I) (*p < 0.05).
(J) Analysis of IL-17 production in CD4+ T cells
of draining LNs from LFD-fed normal mice and
HFD-fed lesional mice by intracellular staining.
Average percentage of IL-17+ cells in total CD4+
T cells is shown in the right panel (*p < 0.05).
Data are shown as mean ± SEM and are repre-
sentative of three experiments. See also Figure S3.we further analyzed T cell infiltration and activation in skin
lesion mice. The numbers of CD4+ T cells and CD8+ T cells
were significantly increased in the lesional skin as compared
to the normal skin of LFD-fed mice (Figure 4B), and they
were extensively accumulated to the epidermal-dermal inter-
face in the lesion areas (Figures 4C and 4D). In the draining
lymph nodes of normal mice, most T cells exhibited naive phe-
notypes (CD4+CD62L+CD44, CD8+CD62L+CD44), whereas
T cells in lymph nodes of mice with skin lesions were switched
to apparent effector or memory phenotypes (Figures 4EImmunity 42, 953–and 4F). More strikingly, these activated
T cells from lesional mice produced
3- to 4-fold higher amounts of IFN-g
than those obtained from normal mice
(Figures 4G–4I). In addition, IL-17 pro-
duction in CD4+ T cells was also higher
in lesional mice than in normal mice
(Figure 4J). In line with the above ob-
servation, T cells in the spleen also
exhibited similar phenotypes and cyto-
kine-producing profiles (Figure S3A–
S3E), suggesting a systemic activation
status of T cells in the HFD-induced
lesional mice. Thus, IL-1b and IL-18might further promote skin inflammation by inducing T cell
activation and cytokine production, such as IFN-g and IL-17,
in the HFD-fed obese mice.
HFD Upregulates E-FABP Expression in Skin Tissues
In search of the underlying mechanisms by which HFD pro-
motes IL-1b and IL-18 production in skin, we reasoned that
FABPs are critical regulators because they coordinate fatty
acid trafficking and biological responses inside cells (Furuhashi
and Hotamisligil, 2008; Chmurzynska, 2006). We first measured964, May 19, 2015 ª2015 Elsevier Inc. 957
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Figure 5. HFD Enhances E-FABP Expression in Skin Tissues
(A) Analysis of the profile of FABP family in normal skin tissues by real-time PCR.
(B) Immunoblotting for E-FABP and A-FABP expression in skin tissues from mice fed the LFD or the HFD for 6 months.
(C) Analysis of E-FABP expression in purified keratinocytes from mice fed the LFD or the HFD for 6 months (*p < 0.05).
(D) Analysis of E-FABP expression in purified CD11c+ macrophages from skin tissues of mice fed the LFD or the HFD for 6 months (**p < 0.01).
(E) Immunohistochemistry (IHC) staining of E-FABP expression (brown) in paraffin-embedded skin sections from mice fed the LFD or the HFD with/without skin
lesions. Hematoxylin was applied for counter staining (blue color). Scale bars represent 25 mM. LFD means 10% fat, HFD means 60% fat.
Data are shown as mean ± SEM and are representative of three experiments. See also Figure S4.the expression profile of the FABP family in skin. As expected,
E-FABP was the most predominant form of FABP family
in skin (Figure 5A). Importantly, HFD upregulated E-FABP
amounts in skin when compared to LFD (Figure 5B). Compared
to the skin of LFD-fed mice, more cells isolated from the skin of
HFD-fed mice expressed intracellular E-FABP, but not A-FABP
(Figures S4A and S4B). Because CD11c+ macrophages were
significantly accumulated in skin tissues of HFD-fed mice (Fig-
ure S2A), we further separated CD11c+ macrophages and ker-
atinocytes by flow sorting and measured E-FABP expression
in these isolated populations. We found that the expression
of E-FABP from the HFD-induced obese mice was 2-fold
higher in keratinocytes, but 6-fold higher in macrophages, as
compared to their respective controls from the LDF-fed lean
mice (Figures 5C and 5D). Immunohistochemistry (IHC) staining
clearly demonstrated that E-FABP expressed in the top layer of
skin epidermis was enhanced in the normal skin of HFD-fed
mice and reached a high level in the HFD-induced lesional
skin (Figure 5E). Notably, inflammatory macrophages with
high E-FABP expression were also extensively infiltrated in
the lesional areas (last panel, Figure 5E). In contrast, E-FABP
expression in the skin of the felt-wheel-induced lesional model
exhibited no obvious elevation when compared to the HFD-
induced spontaneous model (Figure S4C), suggesting that
E-FABP upregulation in the HFD-induced spontaneous lesional
model is not secondary to the inflammatory responses.
Altogether, these results suggest that elevated E-FABP in
the skin of HFD-fed mice is a critical regulator in promoting
HFD-induced skin inflammation.958 Immunity 42, 953–964, May 19, 2015 ª2015 Elsevier Inc.E-FABP Expression Promotes Inflammasome Activation
and Cytokine Production
To assess whether and how E-FABP expression promotes skin
inflammation, we first employed Fabp5+/+ mice and Fabp5/
mice and compared cytokine production by CD11c+ macro-
phages and keratinocytes obtained from these mice. As shown
in Figure 6, E-FABP was not present in skin tissues, including
both CD11c+ macrophages and keratinocytes, of Fabp5/
mice (Figures 6A–6C). When we stimulated bone-marrow-
derived CD11c+ macrophages from Fabp5+/+ and Fabp5/
mice with either saturated FAs or unsaturated FAs, we found
that saturated FAs, but not unsaturated FAs, greatly stimulated
LPS-primed Fabp5+/+ macrophages to produce IL-1b. In
contrast, there was significantly less cytokine production in
FA-stimulated Fabp5/ macrophages (Figure 6D). We further
separated skin CD11c+ macrophages from Fabp5+/+ and
Fabp5/ mice and demonstrated that E-FABP deficiency sig-
nificantly reduced IL-1b production in response to LPS plus
FA stimulation (Figure 6E). These observations indicate that
E-FABP expression in macrophages is essential in promoting
saturated FA-induced cytokine production.
Given the critical role of the inflammasome in governing the
activation of IL-1b processing (Fantuzzi and Dinarello, 1999; Pe´t-
rilli et al., 2007), we next measured NLRP3 expression in satu-
rated FA-stimulated macrophages derived from bone marrow
of Fabp5+/+ and Fabp5/ mice (Figure 6F). Expression of
NLRP3 in Fabp5+/+ macrophages was greatly enhanced above
amounts in Fabp5/ macrophages. In addition, we observed
that the enhanced NLRP3 was exactly co-localized with lipid
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Figure 6. Expression of E-FABP Facilitates FA-Induced Inflammasome Activation and Cytokine Production in Macrophages
(A) IHC staining of E-FABP expression in paraffin-embedded skin tissues from Fabp5+/+ mice and Fabp5/ mice. Scale bars represent 25 mM.
(B and C) Analysis of E-FABP levels in flow-sorted CD11c+ macrophages (B) and keratinocytes (C) from Fabp5+/+ mice and Fabp5/ mice.
(D) Measurement of IL-1b levels in supernatants of resting or LPS-primed bone-marrow-derived CD11c+ macrophages (1 3 106) stimulated with or without
saturated FA (palmitate, 200 mM) or unsaturated FAs (oleate/linoleate, 200 mM) by ELISA (**p < 0.01).
(E) Measurement of IL-1b levels in supernatants of LPS-primed skin CD11c+ macrophages (23 104) stimulated with or without saturated FA (palmitate, 200 mM)
by ELISA (*p < 0.05).
(F) LPS-primed bone-marrow-derived CD11c+macrophages were treated with palmitate for 16 hr and stained for lipid droplet formation (BODIPY, green), NLRP3
expression (red), and nuclei (DAPI, blue) by confocal microscopy. Scale bars represent 10 mM.
(G) ELISA for IL-1b levels in the supernatants of LPS-primed, palmitate-treated CD11c+ macrophages (13 106) in the presence of LD inhibitor Triacsin C (2.5 mM)
(**p < 0.01).
(H) ELISA for IL-1b levels in the supernatants of LPS-primed, oleate/linoleate-treated CD11c+ macrophages (1 3 106) in the presence of LD inhibitor Triacsin C
(2.5 mM) (**p < 0.01).
Data are shown as mean ± SEM and are representative of three experiments. See also Figure S5.droplets (LDs) inside macrophages. E-FABP is the major lipid
carrier facilitating LD formation in CD11c+ macrophages (Zhang
et al., 2014), so we hypothesized that E-FABP might promote
the production of IL-1b by coupling LD formation and NLRP3
inflammasome activation. To this end, we used dietary FAs to
stimulate LPS-primed macrophages with the inhibition of LDformation by Triacsin C (Namatame et al., 1999). IL-1b amounts
in the cultural supernatants of macrophages stimulated with
either saturated FAs or unsaturated FAs were suppressed
with the inhibition of LDs (Figures 6G and 6H). Concomitant
with these observations in CD11c+ macrophages, E-FABP
expression was also required for the IL-1b production inImmunity 42, 953–964, May 19, 2015 ª2015 Elsevier Inc. 959
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Figure 7. E-FABP Deficiency Protects Mice from Development of HFD-Induced Skin Inflammation
(A) Average body weight of Fabp5+/+ and Fabp5/ mice after 3 months to 6 months on the HFD (n = 21/group).
(B) Skin lesion incidence in Fabp5+/+ mice and Fabp5/ mice after 9 months on the HFD (n = 21/group).
(C) Flow cytometric analysis of the infiltration of CD11c+F4/80+ macrophages in skin epidermis from Fabp5+/+ or Fabp5/ mice fed the HFD for 6 months.
Average percentage of CD11c+F4/80+ macrophages is shown in the right panel (*p < 0.05).
(D) ELISA for IL-1b levels in the serum of Fabp5+/+ or Fabp5/ mice fed the HFD for 6 months (**p < 0.01).
(E) ELISA for IL-18 levels in the serum of Fabp5+/+ or Fabp5/ mice fed the HFD for 6 months (*p < 0.05).
(F and G) Analysis of IFN-g production in CD4+ T cells (F) and CD8+ T cells (G) of draining LNs from Fabp5+/+ or Fabp5/ mice fed the HFD for 6 months by
intracellular staining. Average percentage of IFN-g+ cells in total CD4+ or total CD8+ T cells is shown in the right panels (**p < 0.01).
(H) Analysis of IL-17 production in CD4+ T cells of draining LNs from Fabp5+/+ or Fabp5/ mice fed the HFD for 6 months by intracellular staining. Average
percentage of IL-17+ cells is shown in the right panel (*p < 0.05).
Data are shown as mean ± SEM and are representative of three experiments. See also Figure S6.keratinocytes (Figure S5A). Moreover, active Caspase-1 was
co-localized with LDs in keratinocytes (Figure S5B), and inhi-
bition of LDs also inhibited IL-1b production in keratinocytes
(Figure S5C), further suggesting a new function of LDs in facili-
tating the binding and activation of inflammasomes. Lastly,
when we knocked down ASC, a broad inflammasome adaptor,
in macrophages with specific ASC siRNA sets, we showed
that ASC knockdown significantly reduced IL-1b production in
response to LPS and FA stimulation (Figures S5D–S5F), which
was consistent to the results obtained from ASC-deficient
mice (Wen et al., 2011). Altogether, our data indicate that
E-FABP expression in skin tissues is crucial in coupling the
formation of LDs and activation of NLRP3/ASC/Caspase-1 in-
flammasome, thus revealing E-FABP as a new molecular sensor
in fatty-acid-induced inflammatory cytokine production.960 Immunity 42, 953–964, May 19, 2015 ª2015 Elsevier Inc.E-FABP Deficiency Protects Mice against HFD-Induced
Inflammatory Skin Lesions
Having established the critical role of E-FABP in promoting
inflammasome activation and subsequent cytokine production
in vitro, we wanted to determine whether E-FABP expression
instigates HFD-induced skin inflammation in vivo. Fabp5+/+
and Fabp5/ mice were fed the HFD as described above
and were observed for the development of skin lesions. Consis-
tent with previous studies (Maeda et al., 2003), Fabp5/ mice
did not display any apparent alterations in subcutaneous
adiposity (Figure S6A) or total body weight as compared to
Fabp5+/+ mice (Figure 7A). However, after 9 months of the
HDF, 40% of obese Fabp5+/+ mice developed inflammatory
skin lesions with enlarged spleen and draining lymph nodes,
whereas none of Fabp5/ mice exhibited any above
symptoms (Figures 7B, S6B, and S6C). These results further
confirmed that E-FABP expression is decisive for the HFD-
induced skin lesions.
Although consumption of the HFD promoted the accumulation
of CD11c+ macrophages in skin of Fabp5+/+ mice, we found that
very few macrophages, in particular CD11c+ macrophages,
were present in Fabp5/ mice fed the same HFD (Figure 7C),
suggesting an essential role of E-FABP in the HFD-induced dif-
ferentiation of CD11c+ macrophages in vivo. In line with these
observations, serum levels of IL-1b and IL-18 were significantly
higher in Fabp5+/+ mice than those in Fabp5/ mice (Figures
7D and 7E). Thus, E-FABP deficiency alters both macrophage
phenotype and their functions. Furthermore, we also measured
T cell infiltration and activation in Fabp5+/+ and Fabp5/ mice
and demonstrated that fewer T cells were present in skin
epidermis of Fabp5/ mice as compared with Fabp5+/+ mice
(Figure S6D). Importantly, T cells in the draining LNs of Fabp5/
mice produced less IFN-g and IL-17 than cells from Fabp5+/+
mice (Figures 7F–7H). Similarly, E-FABP deficiency in splenic
T cells also impaired their cytokine production (Figure S6E and
S6F). We have shown that E-FABP deficiency in T cells has
no major impact on IFN-g production (Li et al., 2009), and
therefore the elevated IFN-g in obese Fabp5+/+ mice might be
attributed to the elevated IL-1b and IL-18 in these mice. Taken
together, E-FABP deficiency prevents HFD-induced obese
mice from developing skin lesions through altering macrophage
phenotype and consequently their functional profiles that pro-
mote T cell activation.
DISCUSSION
Obesity has been linked to the development of cardiovascular
disease, diabetes, and certain types of cancer (Khandekar
et al., 2011). However, people seldom think of dermatologic con-
ditions with overnutrition status. Besides obesity-associated
physiological alternations of skin, emerging evidence indicates
that obesity is positively correlated with bacterial skin infection
and inflammatory skin disorders (e.g., pruritus, seborrheic
dermatitis) via unknown mechanisms (Mirmirani and Carpenter,
2014). In the present study we demonstrate a clear link between
HFD-induced obesity and the induction of inflammatory skin
lesions in mouse models.
A frequently used model of obesity that closely mirrors the
human situation results from feeding C57BL/6 mice a HFD after
weaning. Considering obesity as a chronic disease, we nor-
mally keep the mice on the HFD for at least half a year to mimic
the long-term effects of elevated body weight. Surprisingly, we
noted a high occurrence of skin lesions in the HFD-fed mice,
but not in the LFD-fed littermates in the same environment,
which hinted to us that this could be a great model to dissect
how excess energy intake interfaces with genetic factors to
promote inflammation in skin tissues. In the process of deter-
mining cellular sensors that induce skin inflammation, our
data suggested a specific phenotype of skin CD11c+ macro-
phages as a key cellular sensor for the HFD-induced skin
inflammation in several aspects. (1) HFD consumption system-
ically enhanced CD11c+ macrophages in the circulation and
promoted their influx in skin tissues before apparent skin
lesions in mice. (2) This population was further accumulatedin lesion areas to promote skin inflammation through produc-
tion of proinflammatory cytokines, mainly as IL-1b and IL-18.
(3) In addition, Fabp5/ mice with reduced influx of CD11c+
macrophages were fully resistant to skin lesions. In line with
our observations, the pathogenic role of CD11c+ macrophages
in promoting insulin resistance as well as adipose tissue inflam-
mation in obese mouse models has been confirmed by other
studies (Patsouris et al., 2008; Lumeng et al., 2007; Wentworth
et al., 2010).
However, some critical questions are raised along these
observations. First, how does consumption of a HFD induce
the differentiation of CD11c+ macrophages? We found that
E-FABP is specifically expressed in CD11c+ macrophages
and its expression levels positively correlate with the intensity
of CD11c in macrophages (Zhang et al., 2014). As a major
fatty acid carrier, E-FABP was significantly upregulated
in macrophages in response to the stimulation of dietary
FAs in vitro (data not shown) and to consumption of the
HFD in vivo, which might thus promote CD11c expression to
facilitate the uptake and processing of the elevated lipids.
In support of this notion, we found that E-FABP deficiency
in obese mice displayed reduced CD11c expression in skin
macrophages. In addition, we noticed that A-FABP, another
FABP family member expressed in macrophages (Makowski
et al., 2005), was not present or expressed at very low
levels in primary CD11c+ macrophages (unpublished data),
further evidence that it is E-FABP that responds to HFD
to regulate CD11c expression in macrophages. The detailed
mechanisms of E-FABP-CD11c interactions are currently under
investigation.
Second, what kinds of factors link HFD to inflammasome
activation and IL-1b release in macrophages? The accumulated
evidence suggests that the mechanisms involved in these bio-
logical events might be multifaceted. For example, saturated
FAs in the HFD have been shown to activate the NLRP3 inflam-
masome through AMPK-autophagy-ROS signaling pathway
(Wen et al., 2011), whereas ceramides (fatty acid metabolites)
can induce NLRP3-Caspase-1 activation and IL-1b release in
macrophages (Vandanmagsar et al., 2011). Moreover, it is
also possible that other lipid components in the HFD, such as
cholesterol, can induce inflammasome activation and IL-1 pro-
duction (Duewell et al., 2010). After carefully analyzing these
studies, we found one common characteristic among these in-
flammasome activators from the HFD: insolubility in aqueous
environments. In other words, these compounds have to be
effectively transported and stabilized in specific niches to acti-
vate inflammasomes inside cells. Intracellular FABPs actively
bind hydrophobic ligands, facilitating their transport and subse-
quent responses (Furuhashi and Hotamisligil, 2008; Chmurzyn-
ska, 2006; Smathers and Petersen, 2011), so it is very likely that
E-FABP expression in CD11c+ macrophages might serve as a
new link between HFD and inflammasome activation. Indeed,
E-FABP deficiency significantly inhibited FA-induced IL-1b
secretion in macrophages. More interestingly, the observations
of colocalization of NLRP3 inflammasome with LDs and sup-
pression of IL-1b by LD inhibition imply that E-FABP-mediated
LD formation provides a new platform for the effective activa-
tion of the inflammasome. Given the unknown cellular localiza-
tion of inflammasomes and underappreciated functions of LDsImmunity 42, 953–964, May 19, 2015 ª2015 Elsevier Inc. 961
(Farese and Walther, 2009; Wang et al., 2013), our data suggest
a new interaction between inflammasomes and LDs. Thus,
E-FABP represents a new molecular link between overnutrition
and metabolic inflammation through coupling fatty acid traf-
ficking and inflammasome activation.
Lastly, although saturated FAs are the major components in
the HFD, whether other unsaturated FAs contribute to skin
inflammation remains unclear. Although LPS-primed CD11c+
macrophages produce a large quantity of IL-1b in response to
palmitate stimulation, they don’t respond to the stimulation of
oleate or linoleate, suggesting a marginal effect of unsaturated
FAs on IL-1b-mediated skin inflammation. Consistent with our
results, unsaturated FAs apart from u-3 FAs have no obvious
effects on NLRP3 activation in macrophages (Yan et al.,
2013). Recently, it was reported that high concentrations of
unsaturated FAs can even prevent the activation of the
NLRP3 inflammsome in macrophages (L’homme et al., 2013).
Considering that defective autophagy can lead to inflamma-
some activation (Nakahira et al., 2011; Wen et al., 2011),
increased autophagy caused by unsaturated FAs might partially
explain why they can inhibit NLRP3 activation (Mei et al., 2011).
Altogether, integration of all evidence indicates that CD11c+
macrophage-mediated chronic skin lesions are mainly induced
by the saturated FAs, but not by the unsaturated components,
in the HFD.
It is worth noting that E-FABP upregulation, especially in the
skin lesional areas, is very striking. This phenomenon was also
observed in other skin disorders, such as psoriasis, with un-
known mechanisms (Ogawa et al., 2011). We noticed that the
HFD slightly enhances gd T cell proliferation in skin. When we
separated gd T cells with a flow sorter and cocultured them
with IL-1b, we found that IL-1b can activate gd T cells to produce
a large amount of keratinocyte growth factor (data not shown),
which might promote keratinocyte proliferation and E-FABP
expression (Jameson and Havran, 2007; Grau et al., 2006).
As discussed above, elevated E-FABP can activate NLRP3-
ASC-Caspase-1 inflammasome and subsequent IL-1b and
IL-18 processing, which in turn exacerbates skin inflammation
by inducing Th1 and Th17 cell adaptive cellular responses
(Chung et al., 2009; Netea et al., 2010; Joosten, 2010). Thus,
our models support a new concept of collaborative effects
between immune cells and local skin cells, in which HFD-
induced skin inflammation is initiated by CD11c+ macrophages,
sustained by gd T cells and keratinocytes, and further escalated
by adaptive T cells.
In conclusion, the present work reveals a novel mechanism
by which consumption of HFD promotes the accumulation of a
specific type of CD11c+ macrophages in skin, which prime
skin to induce IL-1b and IL-18 signaling in response to environ-
mental stimuli (e.g., LPS), and further contributes to keratinocyte
proliferation and effector T cell activation in skin tissues.
More importantly, our data demonstrate that the absence of
E-FABP, a major lipid carrier in CD11c+ macrophages and kera-
tinocytes, results in complete protection against HFD-induced
skin lesions in mice, thereby establishing E-FABP as a new
molecular sensor in HFD-induced skin inflammation. Thus,
E-FABP-mediated inflammation might represent a new mecha-
nism contributing to obesity-related inflammatory diseases not
only in skin but also in other tissues.962 Immunity 42, 953–964, May 19, 2015 ª2015 Elsevier Inc.EXPERIMENTAL PROCEDURES
Mice
Fabp5+/+ mice and Fabp5/ littermates (C57BL/6 background) were bred
and housed in the animal facility in the Hormel Institute in accordance with
University of Minnesota Institutional Animal Care and Use Committee (IACUC).
All animal protocols were approved by IACUC in University of Minnesota
and followed national guidelines. After weaning, male mice were fed ad libitum
either a HFD (60% fat) or a control LFD (10% fat) (Research Diets) for 9 months
for the observation of spontaneous skin lesions. For artificial induction of
skin lesion in lean and obese mice, a felt-wheel-induced skin lesion model
was performed as we previously described (Hayes et al., 2011). In brief,
mice fed the HFD or LFD for 6 months were anesthetized and dorsal back
fur was removed. Dorsum of lean and obese mice was equally abraded with
a felt wheel on a motor tool. Mice were sacrificed 7 days after the abrasion,
and samples were taken for analyses.
Skin Cell Preparation and Stimulation
Dorsal skin from mice was removed and we scraped off the subcutaneous
fat tissues with the back of a no. 10 curved scalpel. After a thorough rinse,
skin was cut into 0.5–1 cm2 squares and digested with Dispase (1.8 U/ml)
(Invitrogen) for 60 min at a 37C incubator with gentle shaking. Epidermis
was separated from dermis and further digested in 3 ml 0.25% Trypsin/
EDTA (Corning Cellgro) in a 37C incubator for 15 min. After single cells
were washed and filtrated through 50 mM nylon filters, they were stained
with various mAb. Mouse skin CD11c+F4/80+ macrophages, gd T cells (CD3+
gdTCR+), and keratinocytes (CD11cF4/80CD3gdTCR) were separated
with a BD FACSAria II Cell Sorter. Bone-marrow-derived CD11c+F4/80+
macrophages were generated as previously described (Zhang et al., 2014).
After skin-separated cells or BM-derived CD11c+ macrophages were pre-
treated with LPS (100 ng/ml), they were stimulated with either palmitate
(200 mM) or oleate/linoleate (200 mM) for 20 hr as indicated. In the experiments
with LD inhibition, keratinocytes or macrophages were stimulated with
saturated or unsaturated FAs in the presence of absence of lipid droplet
inhibitor Triacin C (2 and 5 mM). Culture supernatants were collected for ELISA
measurements of IL-1b (Biolegend) and IL-18 (MBL International Corporation).
Treated cells were analyzed by confocal microscopy or real-time PCR ana-
lyses, respectively.
Flow Cytometric Analysis
Immune cells from skin, peripheral blood (PBMCs), draining lymph nodes, and
spleens were subjected to surface staining or cultured with PMA (5 ng/ml;
Sigma), ionomycin (500 ng/ml; Sigma), and Golgiplug (BD) for 6–8 hr and har-
vested for intracellular staining. Flow cytometric data were collected with BD
FACS Calibur or BD FACSAria II Cell Sorter and analyzed by Flowjo (Tree
Star). See detailed antibodies in the Supplemental Experimental Procedures.
Skin Immunohistochemistry and H&E Staining
Skin samples obtained from Fabp5+/+ or Fabp5/ mice were fixed in 10%
neutral buffered formalin or snap-frozen in cryo-embedding media OCT
(Sakura Finetechnical). The paraffin-embedded samples were cut to 5 mm
sections and stained with hematoxylin and eosin (H&E). For IHC staining, the
sections were blocked with ready-to-use (2.5%) normal horse blocking serum
and then stained with goat anti-E-FABP antibody (R&D Systems) for 1 hr at
room temperature. The sections were developed with Immpress Detection
System (Vector Laboratories) and counterstained with hematoxylin.
Confocal Microscopy
Separated keratinocytes or CD11c+macrophages with designated treatments
were cultured on poly-D-lysine-coated 12 mm coverslips (Neuvitro) in 24-well
plates. After treatment, cells were fixed in 3.7% (w/v) formaldehyde in 0.1 M
phosphate buffer (pH 7.4) at room temperature for 10 min, then permeabilized
in 0.1% Saponin in 1 3 PBS for 10 min at room temperature for lipid droplet
staining by BODIPY 493/503 (Invitrogen) and/or NLRP3-Caspase-1 (Millipore)
staining. The nucleus was stained with 0.2 mMDAPI (Invitrogen). For skin tissue
immunofluorescence staining, frozen sections were blocked and directly
stained with anti-CD4, anti-CD8, anti-CD11c, and anti-F4/80 for 40 min at
room temperature. Confocal analysis was done with Nikon Eclipse TE2000
confocal microscopy.
Quantitative Real-Time PCR
For real-time PCR analysis, RNA was extracted from cells via RNeasy Mini Kit
(QIAGEN). cDNA synthesis was performedwithQuantiTect Reverse Transcrip-
tion Kit (QIAGEN). Quantitative PCR was performed with SYBR Green PCR
Master Mix using ABI 7500 Real-Time PCR Systems (Applied Biosystems).
Relative mRNA levels were determined with b-actin or HPRT1 as a reference
gene. Primer sets other than purchased from QIAGEN are listed in the
Supplemental Experimental Procedures.
Immunoblotting
For measurement of FABP protein levels in skin tissues, cells from skin
epidermis were lysed in buffers with protease inhibitors. For analysis of ASC
expression in macrophages, cells were transfected with 200 nM ASC siRNA
or scramble siRNA (Santa Cruz) by Oligofectamine (Life Technologies) for
24 hr before cells were collected. Protein concentration was determined by
BCA assay (Thermo Scientific). Anti-mouse E-FABP and A-FABP antibodies
(R&DSystems) were used for E-FABP andA-FABP blotting. Anti-ASC antibody
(Millipore) was used for measuring ASC expression. b-actin (Cell Signaling)
was quantified as a loading control. Image Quant TL system was used for
relative protein quantification.
Statistical Analysis
Student’s t test and Z test were utilized for comparison; p value < 0.05 was
considered significantly different.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2015.04.016.
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